Correction to "N-Acetylcysteine Reduces ROS-Mediated Oxidative DNA Damage and PI3K/Akt Pathway Activation Induced by Helicobacter pylori Infection".
Other
Oxidative medicine and cellular longevity
2025
Study Design
- Study Type
- Other
- Population
- Published erratum (correction notice)
- Intervention
- Correction to "N-Acetylcysteine Reduces ROS-Mediated Oxidative DNA Damage and PI3K/Akt Pathway Activation Induced by Helicobacter pylori Infection".
- Effect Direction
- Mixed
- Risk of Bias
- Unclear
Abstract
[This corrects the article DOI: 10.1155/2018/1874985.].
TL;DR
None
Full Text
Used In Evidence Reviews
Similar Papers
Digestion · 2016
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
522 citations
Gut · 1996
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.
297 citations
Open Access
Journal of nanobiotechnology · 2022
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy.
206 citations
Open Access
Frontiers in endocrinology · 2024
The emerging role of oxidative stress in inflammatory bowel disease.
165 citations
Open Access
The British journal of nutrition · 2012
Omega-3 fatty acids and inflammatory bowel diseases - a systematic review.
145 citations
Open Access
Helicobacter · 2007
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
130 citations